VEGFA is already known for its major role in promoting angiogenesis but plays a key factor in tumour-induced immunosuppression through its pleiotropic effects in driving the proliferation of immunosuppressive cell types, limiting T-cell recruitment into tumours, and promoting T-cell exhaustion (Lapeyre-Prost et al. 2017). Here, VEGFA is linked to neoplasm.